Accelerating vaccine development for the fight against COVID-19

“Rapid progress towards the development of potent vaccines can only happen through concerted and coordinated efforts around Europe and the world – and TRANSVAC2 is well positioned to facilitate such efforts.”


Learn how TRANSVAC2 is supporting the Present and transforming the Future of European vaccine R&D landscape not only by answering pressing healthcare challenges as the COVID-19 pandemic, but also in positioning Europe as a global leader in vaccine R&D, in the latest EU Science, Research and Innovation success story.


For the full article: https://ec.europa.eu/research/infocentre/article_en.cfm?artid=49836


TRANSVAC2 Success Story_200709pdf


This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

Be the first to know about the upcoming application calls, follow European Vaccine Initiative on:

  • LinkedIn Social Icon
  • Twitter Social Icon
Subscribe to TRANSVAC´s Mailing list

© 2020 European Vaccine Initiative. Designed by European Vaccine Initiative